Celanese (NYSE:CE) received mixed analyst ratings with 6 analysts offering their perspectives. The average 12-month price target is $156.17, up from $147.60, with a high of $176.00 and a low of $135.00. Analysts from UBS, Keybanc, Citigroup, Piper Sandler, and RBC Capital have adjusted their ratings and price targets. Celanese's financial performance shows strong revenue growth, net margin, ROE, and ROA, but a higher debt-to-equity ratio compared to the industry average.